Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Genotype–Phenotype Spectrum, Socio-Demographic Drivers, and the Protective Impact of Fetal Hemoglobin in Sickle Cell Disease: A Cross-Sectional Analysis from West Bengal, India
Bipasha Banerjee; Tuphan Kanti Dolai; Kaustav Ghosh; Aditi Sen; Abhishek SharmaShow moreShow less
1. Department of Hematology, Nilratan Sircar Medical College and HospitalShow moreShow less
Hemoglobin Fukuyama: First Report of a Rare β-Chain Variant from India
Ruchi Gupta; Alisha Bano; Shivani Kaushal; Akhilesh Sharma; Kusum Gupta; Dinesh Chandra; Rajesh KashyapShow moreShow less
1. Department of Hematology, Sanjay Gandhi Postgraduate Institute of Medical SciencesShow moreShow less
Seasonal, Geographical and Sociodemographic Variation in Coping Strategies Among Individuals with Sickle Cell Disease: A Multisite Study in India
Jatin Sarmah; Trinayani Bordoloi; Yogita Sharma; Madhusmita Bal; Deepa Bhat; Shaily B. Surti; Parikipandla Sridevi; Manoranjan Ranjit; Rabindra K. Jena; Bontha V. BabuShow moreShow less
1. Department of Biotechnology, Bodoland University; 2. Division of Socio-Behavioural, Health Systems & Implementation Research, Indian Council of Medical Research; 3. Division of Molecular Epidemiology, Indian Council of Medical Research-Regional Medical Research Centre; 4. Department of Anatomy, JSS Medical College, JSS Academy of Higher Education and Research; 5. Department of Community Medicine, Parul Institute of Medical Sciences and Research, Parul University; 6. Department of Biotechnology, Central Tribal University of Andhra Pradesh; 7. Department of Clinical Haematology, SCB Medical College, Cuttack, India & Utkal HospitalShow moreShow less
Hb Providence: A Rare Structural Hemoglobin Variant Identified in India
Kaustav Ghosh; Tuphan Kanti Dolai; Shipla RoyShow moreShow less
1. Department of Haematology, Nilratan Sircar Medical College and HospitalShow moreShow less
Precision Medicine in Sickle Cell Disease: From Molecular Pathways to Curative Strategies
Dina Tluli; Omar Tluli; Abdelrahman A. Karen; Mahd M. Abujbara; Omar Sorour; Alaa Abdelhamid; Dahab Ghith; Mohamed A. YassinShow moreShow less
1. College of Medicine, QU Health, Qatar University; 2. Department of Medical Oncology/Hematology, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC)Show moreShow less
An Unusual Presentation of Erythrocytosis Resulting in the Identification of a Novel Unstable Hemoglobin Variant: Hb Koskullskulle HBB : C.311T > C (p.Phe104Ser)
Malin Hultcrantz; Britta LandinShow moreShow less
1. Department of Medicine Solna, Karolinska Institutet; 2. Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; 3. Department of Clinical Chemistry, Karolinska University Hospital; 4. Department of Laboratory Medicine, Karolinska InstitutetShow moreShow less
FAQ
How long does HEMOGLOBIN take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for HEMOGLOBIN. The fastest paper went from submission to acceptance in 1 days (Seasonal, Geographical and Sociodemographic Variation in Coping Strategies Among Individuals with Sickle Cell Disease: A Multisite Study in India, received 2026-09-16, accepted 2026-09-17); the slowest took 316 days. The average is 107.1 days and the median is 108 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
